TY - JOUR
T1 - Depression and congestive heart failure
AU - Guck, Thomas P.
AU - Elsasser, Gary N.
AU - Kavan, Michael G.
AU - Barone, Eugene J.
PY - 2003/1/1
Y1 - 2003/1/1
N2 - The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.
AB - The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.
UR - http://www.scopus.com/inward/record.url?scp=0042821891&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042821891&partnerID=8YFLogxK
U2 - 10.1111/j.1527-5299.2003.01356.x
DO - 10.1111/j.1527-5299.2003.01356.x
M3 - Review article
C2 - 12826775
AN - SCOPUS:0042821891
VL - 9
SP - 163
EP - 169
JO - Prevention and Management of Congestive Heart Failure
JF - Prevention and Management of Congestive Heart Failure
SN - 1527-5299
IS - 3
ER -